About the Company
10x Genomics, Inc. is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness.
Sector
Industrial Applications and Services
Industry
Laboratory Analytical Instruments
Employees
500
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $TXG News
10x Genomics
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...
The Analyst Landscape: 4 Takes On 10x Genomics
Analysts have set 12-month price targets for 10x Genomics, revealing an average target of $54.5, a high estimate of $63.00, ...
10x Genomics Inc Ordinary Shares - Class A
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay
PLEASANTON, Calif., March 26, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of its Visium HD Spatial ...
First Week of TXG June 21st Options Trading
Investors in 10x Genomics Inc (Symbol: TXG) saw new options begin trading this week, for the June 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TXG ...
Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG) and LivaNova (LIVN)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on 10x Genomics (TXG – Research Report) and LivaNova (LIVN – ...
10x Genomics Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay
March 26, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of its Visium HD Spatial Gene Expression ...
10x Genomics Inc Ordinary Shares - Class A
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
10x Genomics Inc.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
10x Genomics, Inc. (TXG)
10x Genomics, Inc. (NASDAQ:TXG) Q4 2023 Earnings Call Transcript February 15, 2024 10x Genomics, Inc. misses on earnings expectations. Reported EPS is $-0.41 EPS, expectations were $-0.36. 10x ...
Loading the latest forecasts...